Listed

Lantheus Holdings, Inc.

LNTHNasdaqCIK 1521036HealthcareFiscal year ends Dec 31

Reports and events: 225 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Lantheus Holdings, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-2207:30 ET8-K8.01 Other events0001193125-26-428324
2026-10-1416:30 ET8-K5.07 Shareholder vote results0001193125-26-421732
2026-10-0217:00 ET8-K8.01 Other events0001193125-26-412563
2026-09-2116:05 ET8-K8.01 Other events0001193125-26-396654
2026-09-0416:40 ETSCHEDULE 13DOwnership report, active investor0001193125-26-383754
2026-08-0608:01 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-336795
2026-08-0607:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-336771
2026-08-0421:00 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-331138
2026-08-0308:37 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-329622
2026-05-0707:44 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-210373
2026-05-0707:36 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-210369
2026-05-0116:30 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-26-201556
2026-03-2016:13 ETDEF 14AProxy statementPeriod 2026-04-300001193125-26-117649
2026-02-2608:00 ET10-KAnnual reportPeriod 2025-12-310001193125-26-073498
2026-02-2607:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-073439
2025-11-1216:30 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-277754
2025-11-0607:48 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-268113
2025-11-0607:39 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-268103
2025-08-1117:02 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-178046
2025-08-0607:51 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-103544
2025-08-0607:39 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-103543
2025-07-2207:31 ET8-K2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-162233
2025-05-0707:41 ET10-QQuarterly reportPeriod 2025-03-310001628280-25-022872
2025-05-0707:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-022871
2025-05-0516:26 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-25-112812
2025-04-0109:12 ET8-K2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-069927
2025-03-2117:23 ETDEF 14AProxy statementPeriod 2025-05-010001193125-25-060360
2025-02-2607:56 ET10-KAnnual reportPeriod 2024-12-310001628280-25-007970
2025-02-2607:42 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-25-007965
2025-01-3008:44 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-25-016381
2025-01-2806:23 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-013841
2025-01-1306:05 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-004904
2024-12-2316:32 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-24-284219
2024-12-1916:30 ET8-K7.01 Regulation FD disclosure0001193125-24-282047
2024-11-2006:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-262071
2024-11-0607:42 ET10-QQuarterly reportPeriod 2024-09-300001628280-24-045459
2024-11-0607:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-045456
2024-09-2516:44 ET8-K7.01 Regulation FD disclosure0001193125-24-226113
2024-09-0508:38 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-24-213726
2024-07-3107:50 ET10-QQuarterly reportPeriod 2024-06-300001628280-24-033630
2024-07-3107:47 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-033629
2024-06-2707:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-24-169713
2024-06-2417:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-167026
2024-05-1516:43 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-24-139440
2024-05-0207:52 ET10-QQuarterly reportPeriod 2024-03-310001628280-24-019798
2024-05-0207:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-019794
2024-04-2916:59 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-24-122683
2024-03-1507:35 ETDEF 14AProxy statementPeriod 2024-04-250001193125-24-068590
2024-02-2207:49 ET10-KAnnual reportPeriod 2023-12-310001628280-24-006158
2024-02-2207:47 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-006157

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:54 ET. Listed shows no prices and gives no investment advice.